Check the name.
Then the claim.

NDC numbers

An NDC is a number identifying a product in a government drug list.

As of September 2026, that listing does not mean approval by the Food and Drug Administration (FDA).

“FDA registered”

Registration records a business that makes medicine; it does not approve that business or its medicines, as of September 2026.

That business may make medicine to order in batches for clinics and hospitals to use, as of September 2026.

“Same as the brand”

Compounded medicines are made to order.

A brand-name medicine can have an approved copy called a generic.

As of September 2026, the FDA says it is false or misleading to call a made-to-order medicine a generic copy of an approved medicine.

The FDA also rejects claims that a made-to-order medicine has been proved to give the same results as an approved medicine, as of September 2026.

A peptide named in an ad

As of September 2026, there is no FDA-approved medicine containing BPC-157 or ipamorelin in the United States.

Lack of approval alone does not tell you whether making a medicine to order is allowed, as of September 2026.

Ask: “Which rule allows you to make this exact medicine for me? Who will make it?”

As of September 2026, the FDA says federal law bars using retatrutide or cagrilintide to make medicine to order.